Yarrow Bioscience, Inc. YARW
14.23 USD -0.12 (-0.84%)
Regular-session close
14.23 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
13.84 Day range 14.83
12.39 52-week range 46.95
- YTD
- -50.93%
- 1 year
- -20.94%
News
benzinga.com This Centrus Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Analysts initiated coverage on CI (In-Line, $290), LEU (Overweight, $130), YARW (Buy, $40), SGHC (Equal-Weight, $13) and OFG (Sell, $50).benzinga.com Jefferies Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $40 Jefferies analyst Faisal Khurshid initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $40.
benzinga.com Yarrow Bioscience Q3 EPS $(0.43) Misses $(0.32) Estimate Yarrow Bioscience (NASDAQ:YARW) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.32) by 34.37 percent.
businesswire.com Yarrow Bioscience Reports Third Quarter 2026 Financial Results and Provides Business Update NEW HAVEN, Conn.--(BUSINESS WIRE)--Yarrow Bioscience, Inc. (“Yarrow” or the “Company”) (Nasdaq: YARW), a clinical-stage biotechnology company focused on developing transformative therapies for…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Lisata Therapeutics (NASDAQ:LSTA) stock rose 37.2% to $1.4 during Wednesday's regular session. The market value of their outstanding shares is at $11.0 million. BioStem Technologies…
benzinga.com This Palatin Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday Analysts initiated coverage: Neutral on KEEL ($2), Buy on PTN ($12), FRVO ($17) and YARW ($60).benzinga.com Guggenheim Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $60 Guggenheim analyst Yatin Suneja initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $60.
